Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (111-120 of 542) with videos related to

Pageof 55
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1984
In vitro antibacterial activity of cefpiramideM A Pfaller, A C Niles, P R Murray
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United StatesD J Biedenbach, R N Jones, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1993
Evaluation of disk susceptibility testing of fosfomycin tromethamineM A Pfaller, A L Barry, P C Fuchs
Journal of Clinical Microbiology|August 1, 1993
Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacinP C Fuchs, A L Barry, M A Pfaller
Diagnostic Microbiology and Infectious Disease|March 7, 1998
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study GroupM A Pfaller, R N Jones, G V Doern
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1992
Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacinA L Barry, M A Pfaller, P C Fuchs
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Antifungal susceptibility testing: technical advances and potential clinical applicationsM A Pfaller, J H Rex, M G Rinaldi
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)M A Pfaller, R N Jones, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|March 8, 2000
In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methodsR E Lewis, M E Klepser, M A Pfaller
Diagnostic Microbiology and Infectious Disease|July 13, 2001
Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulinM A Pfaller, R N Jones, D H Walter, et al.
Pageof 55

Showing results (111-120 of 542) with videos related to

Sort By:
Pageof 55
Antimicrobial Agents and Chemotherapy|March 1, 1984
In vitro antibacterial activity of cefpiramideM A Pfaller, A C Niles, P R Murray
Diagnostic Microbiology and Infectious Disease|June 19, 2001
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United StatesD J Biedenbach, R N Jones, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1993
Evaluation of disk susceptibility testing of fosfomycin tromethamineM A Pfaller, A L Barry, P C Fuchs
Journal of Clinical Microbiology|August 1, 1993
Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacinP C Fuchs, A L Barry, M A Pfaller
Diagnostic Microbiology and Infectious Disease|March 7, 1998
Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study GroupM A Pfaller, R N Jones, G V Doern
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1992
Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacinA L Barry, M A Pfaller, P C Fuchs
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Antifungal susceptibility testing: technical advances and potential clinical applicationsM A Pfaller, J H Rex, M G Rinaldi
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)M A Pfaller, R N Jones, D J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|March 8, 2000
In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methodsR E Lewis, M E Klepser, M A Pfaller
Diagnostic Microbiology and Infectious Disease|July 13, 2001
Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulinM A Pfaller, R N Jones, D H Walter, et al.
Pageof 55